Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173394 | SCV000224503 | uncertain significance | not provided | 2015-02-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000173394 | SCV001727596 | benign | not provided | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002517664 | SCV003626667 | uncertain significance | Inborn genetic diseases | 2021-12-14 | criteria provided, single submitter | clinical testing | The c.103G>C (p.E35Q) alteration is located in exon 1 (coding exon 1) of the PROM1 gene. This alteration results from a G to C substitution at nucleotide position 103, causing the glutamic acid (E) at amino acid position 35 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |